Is CDLX a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Stabilizing billings after the bank partner loss, with revenue (ttm, continuing ops) at ~$169M. The bear case rests on the central risk is the capital structure: at roughly $12 million of market value, the equity is small next to $172.5 million of convertible notes due April 2029 and a $15.0 million credit line, and stockholders' equity was already a $16.0 million deficit at June 30, 2026, so a refinancing or exchange could heavily dilute or largely wipe out existing shareholders. Analysts covering it are spread from $4.00 to $10.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The central risk is the capital structure: at roughly $12 million of market value, the equity is small next to $172.5 million of convertible notes due April 2029 and a $15.0 million credit line, and stockholders' equity was already a $16.0 million deficit at June 30, 2026, so a refinancing or exchange could heavily dilute or largely wipe out existing shareholders. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $4.00, +94.2% from the $2.06 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Stabilizing billings after the bank partner loss. Billings fell 34% year over year to $65.5 million in Q2 2026, and Q3 guidance of $61 million to $67 million implies another 20% to 27% decline. The most optimistic analyst target on CDLX is $10.00, +385.4% from the $2.06 price. That figure is only reachable if this thesis works close to its best case.

The central risk is the capital structure: at roughly $12 million of market value, the equity is small next to $172.5 million of convertible notes due April 2029 and a $15.0 million credit line, and stockholders' equity was already a $16.0 million deficit at June 30, 2026, so a refinancing or exchange could heavily dilute or largely wipe out existing shareholders. Cash fell to $28.0 million at mid-2026 with free cash flow of about negative $18.6 million in the first half, and the credit line requires at least $20.0 million of unrestricted cash plus a minimum adjusted EBITDA, which leaves a thin buffer. The 10-K says the company is substantially dependent on Chase, Wells Fargo and a few other FI partners, and losing one large US partner has already cut revenue by about a third. Banks can build their own offer programs or switch providers, and rules on sharing consumer financial data could change what partners may provide. Advertiser budgets are cyclical, and management cited quick-service restaurant spending shifting toward delivery. Listing risk remains: the June 2026 reverse split followed a Nasdaq bid-price notice, and the stock has roughly halved since. Goodwill of $110.3 million on the US business is flagged in the 10-Q as susceptible to impairment. Leadership has turned over, with a new CFO in early 2026 and the chief legal officer leaving in July 2026, and insiders filed Form 144 notices of planned sales in July, August and October 2026. The most pessimistic published target is $4.00, +94.2% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Atlanta-based ad network that places brand cash-back offers inside the mobile and online banking apps of Chase, Wells Fargo, American Express and other banks.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Stabilizing billings after the bank partner loss) stalling in the reported numbers rather than in the narrative, the risk above (the central risk is the capital structure: at roughly $12 million of market value, the equity is small next to $172.5 million of convertible notes due April 2029 and a $15.0 million credit line, and stockholders' equity was already a $16.0 million deficit at June 30, 2026, so a refinancing or exchange could heavily dilute or largely wipe out existing shareholders) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

Cardlytics runs an advertising network inside banks' websites and mobile apps. Using anonymized transaction data shared by its bank partners, it shows customers cash-back offers from brands, and charges those brands when customers who were shown the offer go on to shop with them. Part of each fee funds the customer's reward and part goes to the bank as Partner Share. It operates in the United States and the United Kingdom.

Yes. Cardlytics effected a 1-for-10 reverse stock split on June 5, 2026, after Nasdaq notified it on June 3, 2026 that its shares had closed below $1.00 for 30 consecutive business days. Every ten old shares became one new share, cutting the share count to ~5.8 million. Historical prices and per-share figures are restated for the split, so pre-2026 charts now show prices ten times higher than they traded at.

No. Cardlytics has never paid a dividend and is losing money on a GAAP basis, with negative free cash flow and a stockholders' deficit as of June 30, 2026. Its cash priorities are funding operations, maintaining the $20 million minimum cash its credit line requires, and dealing with $172.5 million of convertible notes due in 2029, so a dividend is not part of the picture.